SCHEMBL9104224

SCHEMBL9104224

CC(C)CC(C(=O)Nc1nccs1)N1C(=O)Cc2cc(OC(F)(F)F)ccc21

nearest known ligand 0.53

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
GCK P35557 6/20 0.53
KCNA5 P22460 1/20 0.43
FFAR2 O15552 1/20 0.40
LMNA P02545 3/20 0.39
SCN5A Q14524 1/20 0.39
SCN9A Q15858 1/20 0.39
HSPA5 P11021 1/20 0.39
HSPA2 P54652 1/20 0.39
ALDH1A1 P00352 2/20 0.38
KDM4E B2RXH2 1/20 0.38
HPGD P15428 1/20 0.38
HSD17B10 Q99714 1/20 0.38
MEN1 O00255 1/20 0.38
NPC1 O15118 1/20 0.38
RAB9A P51151 1/20 0.38
KMT2A Q03164 1/20 0.38
NTRK1 P04629 2/20 0.38
XBP1 P17861 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9106645 0.90 GCK (0.56) GCKKCNA5FFAR2LMNAHSPA5
SCHEMBL9106223 0.86 GCK (0.49) GCK
SCHEMBL9105720 0.86 GCK (0.58) GCKKCNA5FFAR2LMNAHSPA5
SCHEMBL9106638 0.85 GCK (0.59) GCKFFAR2LMNAHSPA5HSPA2
SCHEMBL9106279 0.84 GCK (0.58) GCKFFAR2LMNAHSPA5HSPA2
SCHEMBL9105123 0.84 GCK (0.58) GCKFFAR2LMNAHSPA5HSPA2
SCHEMBL9107671 0.84 RAB9A (0.38) GCKLMNASCN9AALDH1A1KDM4E
SCHEMBL9108208 0.83 RAB9A (0.37) GCKFFAR2KDM4ENPC1RAB9A
SCHEMBL9908089 0.83 RAB9A (0.37) GCKFFAR2KDM4ENPC1RAB9A
SCHEMBL9103208 0.82 GCK (0.68) GCKFFAR2LMNAHSPA5HSPA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120142705-A1 ISATIN AND OXINDOLE COMPOUNDS KESTER ROBERT FRANCIS (US) 2012-06-07 US claimed
US-20120142705-A1 ISATIN AND OXINDOLE COMPOUNDS KESTER ROBERT FRANCIS (US) 2012-06-07 US disclosed
US-20120142705-A1 ISATIN AND OXINDOLE COMPOUNDS KESTER ROBERT FRANCIS (US) 2012-06-07 US disclosed
US-20120142705-A1 ISATIN AND OXINDOLE COMPOUNDS KESTER ROBERT FRANCIS (US) 2012-06-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120142705-A1 ISATIN AND OXINDOLE COMPOUNDS GPR119, INSR, OAT GCK 488/4885KCNA5 4229/4885FFAR2 627/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.